Modular Medical, Inc. (MODD)
Market Cap | 60.43M |
Revenue (ttm) | n/a |
Net Income (ttm) | -16.76M |
Shares Out | 30.99M |
EPS (ttm) | -0.97 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 145,012 |
Open | 1.940 |
Previous Close | 1.950 |
Day's Range | 1.842 - 1.990 |
52-Week Range | 0.840 - 2.220 |
Beta | -3.72 |
Analysts | Buy |
Price Target | 4.25 (+129.73%) |
Earnings Date | Feb 13, 2024 |
About MODD
Modular Medical, Inc. operates as a development stage medical device company. It focuses on the design, development, and commercialization of insulin pumps. It offers MODD1, a two-part patch pump for diabetes. The company was founded in 1998 and is headquartered in San Diego, California. [Read more]
Financial Performance
Financial StatementsAnalyst Forecast
According to 2 analysts, the average rating for MODD stock is "Buy." The 12-month stock price forecast is $4.25, which is an increase of 129.73% from the latest price.
News
Modular Medical Announces Steve Gemmell as New Vice President of Engineering
SAN DIEGO, CA / ACCESSWIRE / March 26, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), a development-stage, insulin delivery technology company seeking to launch the n...
Registration Is Now Open for Tribe Public's Webinar Event "Revolutionizing Diabetes Care" Featuring Modular Medical CEO on Wednesday, March 6, 2024
Meet with Modular Medical CEO, Jeb Besser There are more than 3 million individuals who use daily insulin to help with the care of Diabetes in the US. 100% of patient population require daily insulin ...
Modular Medical Announces Closing of $10 Million Public Offering
SAN DIEGO, CA / ACCESSWIRE / February 21, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), a development stage insulin delivery technology company seeking to launch the...
Modular Medical Announces Pricing of $10 Million Public Offering
SAN DIEGO, CA / ACCESSWIRE / February 15, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), a development stage insulin delivery technology company seeking to launch the...
Modular Medical Announces Proposed Public Offering
SAN DIEGO, CA / ACCESSWIRE / February 15, 2024 / Modular Medical, Inc. (Nasdaq:MODD) ("Modular Medical"), a development stage insulin delivery technology company seeking to launch the next generation ...
Modular Medical Announces Issuance of New US Patent
SAN DIEGO, CA / ACCESSWIRE / January 24, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), a development-stage, insulin delivery technology company seeking to launch the...
Modular Medical Announces 510(k) Submission of MODD1 Insulin Pump
SAN DIEGO, CA / ACCESSWIRE / January 19, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), a development-stage, insulin delivery technology company seeking to launch the...
Modular Medical Announces Collaboration with Glooko
SAN DIEGO, CA / ACCESSWIRE / December 21, 2023 / Modular Medical, Inc. (Nasdaq:MODD) ("Modular Medical" or the "Company"), a development-stage, insulin delivery technology company seeking to launch th...
Registration Is Now Open For Tribe Public's Webinar Event "Diabetes Care For The Rest Of Us." Featuring Modular Medical CEO On Friday, December 15, 2023
Meet with Modular Medical CEO, Jeb Besser There are more than 3 million individuals who use daily insulin to help with the care of Diabetes in the US. 100% of patient population require daily insulin ...
Modular Medical to Attend the Benchmark Company's Upcoming Discovery One-on-One Investor Conference
SAN DIEGO, CA / ACCESSWIRE / November 14, 2023 / Modular Medical, Inc. (Nasdaq:MODD) ("Modular Medical" or the "Company"), a development-stage, insulin delivery technology company seeking to launch th...
Modular Medical Updates Test Progress and Submission Timeline
SAN DIEGO, CA / ACCESSWIRE / October 31, 2023 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), a development stage insulin delivery technology company seeking to launch the ...
Modular Medical Partners with Phillips-Medisize to Expand Insulin Delivery Alternatives
SAN DIEGO, CA / ACCESSWIRE / August 16, 2023 / Modular Medical, Inc. (Nasdaq:MODD), a development stage insulin delivery technology company seeking to launch the next generation of user-friendly and a...
Modular Medical to Present at the Sidoti Micro-Cap Virtual Conference on August 17
SAN DIEGO, CA / ACCESSWIRE / August 10, 2023 / Modular Medical, Inc. (the "Company" or "Modular Medical") (Nasdaq:MODD), a development stage insulin delivery technology company seeking to launch the n...
Modular Medical Announces Diabetes Industry Veteran Duane DeSisto Will Join the Board of Directors
SAN DIEGO, CA / ACCESSWIRE / July 6, 2023 / Modular Medical, Inc. (the "Company" or "Modular Medical") (NASDAQ:MODD), a development stage insulin delivery technology company seeking to launch the next...
Modular Medical Announces Full Exercise of Underwriter's Option to Purchase Additional Shares
SAN DIEGO, CA / ACCESSWIRE / May 25, 2023 / Modular Medical, Inc. (the "Company" or "Modular Medical") (Nasdaq:MODD), a development stage insulin delivery technology company seeking to launch the next...
Modular Medical Announces Pricing of Upsized $9.4 Million Public Offering
SAN DIEGO, CA / ACCESSWIRE / May 16, 2023 / Modular Medical, Inc. (the "Company" or "Modular Medical") (Nasdaq:MODD), a development stage insulin delivery technology company seeking to launch the next...
Modular Medical Provides Update on FDA Submission Strategy
SAN DIEGO, CA / ACCESSWIRE / January 25, 2023 / Modular Medical, Inc. (the "Company" or "Modular Medical") (NASDAQ:MODD), a development stage insulin delivery technology company seeking to launch the ...
Modular Medical Announces Product Testing Update
SAN DIEGO, CA / ACCESSWIRE / November 28, 2022 / Modular Medical, Inc. (the "Company" or "Modular Medical") (NASDAQ:MODD), a development stage, insulin delivery technology company seeking to launch th...
Modular Medical Announces Participation at Upcoming Investor Conferences
SAN DIEGO, CA / ACCESSWIRE / November 23, 2022 / Modular Medical, Inc. (the "Company" or "Modular Medical") (NASDAQ:MODD), a development stage, insulin delivery technology company seeking to launch th...
Modular Medical Provides Product Update
SAN DIEGO, CA / ACCESSWIRE / October 3, 2022 / Modular Medical Inc. (the "Company" or "Modular Medical") (NASDAQ:MODD), a development stage, insulin delivery technology company seeking to launch the n...
Dr. Anne Peters Joins the Modular Medical Advisory Board
Dr. Peters, a prominent diabetes clinician and clinical researcher, is a leading voice in the fight to bring diabetes technology and therapeutics to under-resourced communities SAN DIEGO, CA / ACCESSW...
Modular Medical Appoints Kevin Schmid as Chief Operating Officer
Schmid brings 40 years of experience in medical devices for drug delivery and diabetes management and a background in high-volume manufacturing SAN DIEGO, CA / ACCESSWIRE / July 26, 2022 / Modular Med...
Modular Medical to Present at LD Micro Invitational XII Investor Conference
SAN DIEGO, CA / ACCESSWIRE / June 2, 2022 / Modular Medical Inc. (the "Company" or "Modular Medical") (NASDAQ:MODD), a development stage, insulin delivery technology company seeking to launch the next...
Modular Medical to Present at Spring Into Action - Best Ideas Virtual Investor Conference on May 18, 2022
SAN DIEGO, CA / ACCESSWIRE / May 12, 2022 / Modular Medical, Inc. ("Modular Medical") (NASDAQ:MODD), a development stage, insulin delivery technology company seeking to launch the next generation of e...
Modular Medical Announces $8 Million Registered Direct Offering
SAN DIEGO, CA / ACCESSWIRE / May 3, 2022 / Modular Medical, Inc. (the "Company" or "Modular Medical") (NASDAQ:MODD), today announced that it has entered into a securities purchase agreement with insti...